Frank Mottola - Net Worth and Insider Trading
Frank Mottola Net Worth
The estimated net worth of Frank Mottola is at least $299,874 dollars as of 2024-12-01. Frank Mottola is the SVP, Quality, GMP, Ops, IT of Supernus Pharmaceuticals Inc and owns about 8,200 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $299,874. Details can be seen in Frank Mottola's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank Mottola has not made any transactions after 2024-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frank Mottola
Frank Mottola Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Mottola owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .
Click here to see the complete history of Frank Mottola’s form 4 insider trades.
Insider Ownership Summary of Frank Mottola
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2024-11-07 | Sr VP & Quality & GMP Oper. & IT |
Frank Mottola Latest Holdings Summary
Frank Mottola currently owns a total of 1 stock. Frank Mottola owns 8,200 shares of Supernus Pharmaceuticals Inc (SUPN) as of November 7, 2024, with a value of $299,874.
Latest Holdings of Frank Mottola
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2024-11-07 | 8,200 | 36.57 | 299,874 |
Holding Weightings of Frank Mottola
Frank Mottola Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Mottola has made a total of 3 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 15,000 shares on November 7, 2024, which brought Frank Mottola around $554,700.
Insider Trading History of Frank Mottola
- 1
Frank Mottola Trading Performance
Frank Mottola Ownership Network
Frank Mottola Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Frank Mottola is the Sr VP & Quality & GMP Oper. & IT of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include director & President & CEO Jack A. Khattar , Sr. VP of IP & CSO Padmanabh P. Bhatt , and Sr. V.P. & Regulatory Affairs Tami Tillotson Martin .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Frank Mottola made 2 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 16,110. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 21,235 shares made by Tami Tillotson Martin .
In summary, during the past 3 months, insiders sold 323,308 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 323,308 shares. During the past 18 months, 455,751 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 455,751 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
Frank Mottola Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Mottola. You might contact Frank Mottola via mailing address: 9715 Key West Avenue, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
